Concentric Analgesics Revenue and Competitors

Location

$20M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Concentric Analgesics's estimated annual revenue is currently $47.9M per year.(i)
  • Concentric Analgesics's estimated revenue per employee is $1,596,500
  • Concentric Analgesics's total funding is $20M.

Employee Data

  • Concentric Analgesics has 30 Employees.(i)
  • Concentric Analgesics grew their employee count by 25% last year.

Concentric Analgesics's People

NameTitleEmail/Phone
1
Co-Founder (VP - Chemistry)Reveal Email/Phone
2
CEOReveal Email/Phone
3
Head Clinical OperationsReveal Email/Phone
4
EVP, DevelopmentReveal Email/Phone
5
VP, Head Clinical DevelopmentReveal Email/Phone
6
Sr. Director, CMCReveal Email/Phone
7
President and Chief Scientific OfficerReveal Email/Phone
8
Senior DirectorReveal Email/Phone
9
Associate Director, Clinical OperationsReveal Email/Phone
10
Bioanalytical ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Concentric Analgesics?

Concentric Analgesics, Inc. is a private, biotechnology company focused on discovering and developing novel, non-opioid therapeutics for the management of acute and chronic pain.

keywords:N/A

$20M

Total Funding

30

Number of Employees

$47.9M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Concentric Analgesics News

2022-04-06 - Clinical Catch-Up: Adagio to Seek COVID-19 EUA, CytoDyn's Bad ...

Concentric Analgesics completed its Phase II trial of vocacapsaicin in patients undergoing open laparotomy for ventral hernia repair.

2022-03-30 - Concentric Analgesics Announces Positive Results from Pilot Phase ...

Concentric Analgesics is a clinical-stage, biopharmaceutical company focused on developing and commercializing novel, non-opioid pain...

2022-02-22 - Concentric Analgesics Announces Completion of $20 Million ...

Concentric Analgesics is a clinical-stage, biopharmaceutical company focused on developing and commercializing novel, non-opioid pain...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M303%N/A
#2
$4.7M30-48%$29.6M
#3
$3.2M30-25%$21.3M
#4
$3.8M30N/AN/A
#5
$3.3M30-70%$2M